申请人:Abbott Laboratories
公开号:US06166019A1
公开(公告)日:2000-12-26
Compounds of Formula I and II and their pharmaceutically acceptable, salts, esters and prodrugs thereof are selective alpha-1D adrenoceptor anatagonists and may be useful for treating disease states.
公式I和II的化合物及其药用可接受的盐、酯及其前药是选择性α-1D肾上腺素受体拮抗剂,可能对治疗疾病状态有用。